SEC Form 4 · accession 0001144204-16-109515
BRAINSTORM CELL THERAPEUTICS INC. · BCLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G L Shorr
Director
Period of report
Jun 22, 2016
Accepted (ET)
Jun 23, 2016 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137883
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 22, 2016 | A | 8,666 | $0.00 | A | 37,065 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares acquired are shares of restricted stock awarded on June 22, 2016 pursuant to the Brainstorm Cell Therapeutics Inc. Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on July 22, 2016 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.